基本信息
浏览量:193
职业迁徙
个人简介
Nagy Habib is a leading translational researcher on liver cancer and its treatment. He pioneered the first clinical trial in the use of adenovirus and plasmid for the treatment of liver cancer, as well as the use of plasmid gene therapy in hydrodynamic gene delivery. He is the first person in the West to publish a clinical trial on the use of adult bone marrow derived stem cells for the treatment of patients with liver insufficiency.
He has published on the evolution of molecular biology of tumors from oncogene, tumor suppressor gene, epigenetic modification, genetherapy, stem cell therapy, RNA (Ribonucleic acid) and saRNA (small activating RNA) and RNA aptamers.
He is the inventor of, and was co-author of the first publication about the use for radiofrequency in devices used in liver surgery (Habib 4X), as well as interventional endoscopy (Habib EndoHPB – HPB: Hepatopancreatobiliary) and interventional radiology (Habib Percutaneous HPB, Habib VesCoag, Habib VesOpen).
Nagy is currently Lead Clinician and Head of the Department of HPB Surgery at Imperial College London. In June 2007 he was also appointed Pro Rector for Commercial Affairs at the university.
He holds a gold award from the Advisory Committee for Clinical Excellence, which is given in recognition of exceptional contributions from NHS consultants, and he was named as one of Britain’s top surgeons in December 2011 by the Saturday Times Magazine. In December 2012, he was awarded the TAKREEM AWARD for Science and Technology for scientific work in liver cancer and the technological development of the Habib 4X surgical device.
AWARDS
Board Member International Centre of Excellence for Technical Innovation in Surgery, University of Naples, Itlay, 2017
Honorary Foreign Member, French Academy of Surgery, 2015
Honorary Diploma, Bulgarian Surgical Society, 2014
Scientific and Technological Achievement, TAKREEM, 2012
Named as one of top 100 surgeons in the UK, The Times newspaper, 2011
Doctor Honoris Causa, University of Medicine and Pharmacy, Cluj-Napoca, Romania, 2011
Gold Clinical Excellence Award, ACCEA, 2011
Visiting Professor of Hepatic Surgery, First Affiliated Hospital of Harbin Medical University, 2010
Visiting Professor of Hepatobiliary Department, Tainjian Medical Univeristy Cancer Institute, 2010
EXTERNAL POSITIONS
Peer Reviewer, PhD Committee, Univeristy of Messina, Department of Pathology, Italy, 2010
Board Member, International Association of Surgeons and Gastroenterologists, 2005
President, Past President and Board Member, International Society of Cell & Gene Therapy of Cancer, 2003 - 2017
MEMBERSHIP OF PROFESSIONAL BODIES
Full Member, American Association for Cancer Research, 2017
Full Member, London Regenerative Medicine Network, 2017
Full Member, European Surgical Association, 2010
Full Member and Past President, International Society of Cell and Gene Therapy for Cancer, 2004
Full Member, Oligonucleotide Therapeutics Society, 2002
Full Member, American Society for Gene and Cell Therapy, 2000
Full Member, American Association for study of the Liver Diseases, 2000
Full Member, American Association of Clinical Oncology, 2000
Full Member, International Hepato-Pancreato-Biliary Association, 2000
He has published on the evolution of molecular biology of tumors from oncogene, tumor suppressor gene, epigenetic modification, genetherapy, stem cell therapy, RNA (Ribonucleic acid) and saRNA (small activating RNA) and RNA aptamers.
He is the inventor of, and was co-author of the first publication about the use for radiofrequency in devices used in liver surgery (Habib 4X), as well as interventional endoscopy (Habib EndoHPB – HPB: Hepatopancreatobiliary) and interventional radiology (Habib Percutaneous HPB, Habib VesCoag, Habib VesOpen).
Nagy is currently Lead Clinician and Head of the Department of HPB Surgery at Imperial College London. In June 2007 he was also appointed Pro Rector for Commercial Affairs at the university.
He holds a gold award from the Advisory Committee for Clinical Excellence, which is given in recognition of exceptional contributions from NHS consultants, and he was named as one of Britain’s top surgeons in December 2011 by the Saturday Times Magazine. In December 2012, he was awarded the TAKREEM AWARD for Science and Technology for scientific work in liver cancer and the technological development of the Habib 4X surgical device.
AWARDS
Board Member International Centre of Excellence for Technical Innovation in Surgery, University of Naples, Itlay, 2017
Honorary Foreign Member, French Academy of Surgery, 2015
Honorary Diploma, Bulgarian Surgical Society, 2014
Scientific and Technological Achievement, TAKREEM, 2012
Named as one of top 100 surgeons in the UK, The Times newspaper, 2011
Doctor Honoris Causa, University of Medicine and Pharmacy, Cluj-Napoca, Romania, 2011
Gold Clinical Excellence Award, ACCEA, 2011
Visiting Professor of Hepatic Surgery, First Affiliated Hospital of Harbin Medical University, 2010
Visiting Professor of Hepatobiliary Department, Tainjian Medical Univeristy Cancer Institute, 2010
EXTERNAL POSITIONS
Peer Reviewer, PhD Committee, Univeristy of Messina, Department of Pathology, Italy, 2010
Board Member, International Association of Surgeons and Gastroenterologists, 2005
President, Past President and Board Member, International Society of Cell & Gene Therapy of Cancer, 2003 - 2017
MEMBERSHIP OF PROFESSIONAL BODIES
Full Member, American Association for Cancer Research, 2017
Full Member, London Regenerative Medicine Network, 2017
Full Member, European Surgical Association, 2010
Full Member and Past President, International Society of Cell and Gene Therapy for Cancer, 2004
Full Member, Oligonucleotide Therapeutics Society, 2002
Full Member, American Society for Gene and Cell Therapy, 2000
Full Member, American Association for study of the Liver Diseases, 2000
Full Member, American Association of Clinical Oncology, 2000
Full Member, International Hepato-Pancreato-Biliary Association, 2000
研究兴趣
论文共 329 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
BIOPHYSICAL CHEMISTRY (2024)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 11 (2024)
BJS openno. 3 (2024)
Gastroenterologyno. 5 (2024): S-1794-S-1795
Journal of Vascular and Interventional Radiologyno. 3 (2024): S11-S12
Journal of clinical medicineno. 7 (2024): 2128-2128
Journal of Vascular and Interventional Radiology (2023)
Debashis Sarker,Ruth Plummer,Tim Meyer,Mikael H. Sodergren,Bristi Basu, Cheng Ean Chee,Kai‐Wen Huang,Daniel H. Palmer, Yuk Ting,T.R. Jeff Evans,Duncan Spalding,Madhava Pai,Rohini Sharma, David J. Pinato,James Spicer,Sarah B. Hunter, Vineet Kwatra,Joanna P. Nicholls,David Collin, Robert Nutbrown, Helen Glenny, Sonia Fairbairn, Vikash Reebye,Jon Voutila,Stephanie Dorman,Pinelopi Andrikakou, Peter Lloyd, Steve Felstead,Jenni Vasara,Nagy Habib, Chris M. Wood, Pål Sætrom,Hans E. Huber,David C. Blakey, John J. Rossi
openalex
CANCERSno. 22 (2023): 5492
Debashis Sarker,Ruth Plummer,Tim Meyer,Mikael H. Sodergren,Bristi Basu, Cheng Ean Chee,Kai-Wen Huang,Daniel H. Palmer,Yuk Ting Ma,T.R. Jeff Evans,Duncan R.C. Spalding,Madhava Pai,Rohini Sharma, David J. Pinato,James Spicer,Sarah Hunter, Vineet Kwatra,Joanna P. Nicholls,David Collin, Robert Nutbrown, Helen Glenny, Sonia Fairbairn, Vikash Reebye,Jon Voutila,Stephanie Dorman,Pinelopi Andrikakou, Peter Lloyd, Steve Felstead,Jenni Vasara,Robert Habib, Chris Wood, Pal Saetrom,Hans E. Huber,David C. Blakey, John J. Rossi,Nagy Habib
crossref(2023)
加载更多
作者统计
#Papers: 329
#Citation: 9427
H-Index: 50
G-Index: 86
Sociability: 7
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn